• News
  • SAN DIEGO
  • BioTech

J&J diabetes pill may cause heart risk, FDA staff says

Jan. 8 (Bloomberg) -- Johnson & Johnson’s experimental diabetes drug canagliflozin may have heart risks, U.S. regulators said.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!